Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Eton Pharmaceuticals (NASDAQ: ETON) will report first quarter 2026 financial results on Thursday, May 14, 2026, and will host a conference call and live audio webcast at 4:30 p.m. ET (3:30 p.m. CT).

Rhea-AI Summary

Eton Pharmaceuticals (NASDAQ: ETON) will report first quarter 2026 financial results on Thursday, May 14, 2026, and will host a conference call and live audio webcast at 4:30 p.m. ET (3:30 p.m. CT).

Management will take live questions on the call and answer emailed investor questions sent to investorrelations@etonpharma.com. The live webcast is available on the company's Investors website, with an archived webcast posted about two hours after the event and available for 30 days.

Argus May 5 session

+0.73% close to close Open Argus

Details

News Market Reaction – ETON

On May 5, the first trading day after this news, ETON closed 0.73% above the previous close.

Data tracked by StockTitan Argus for the May 5 session.

Market Context

This announcement sets the timing for first quarter 2026 results on May 14, 2026, with a conference ...

Analysis

This announcement sets the timing for first quarter 2026 results on May 14, 2026, with a conference call at 4:30 p.m. ET and a webcast replay available for 30 days. It follows recent clinical, acquisition, and financial milestones, so upcoming results may be viewed in that broader context. Investors may focus on revenue trends, profitability metrics, and updates on key products and pipeline programs when the quarter is reported.

Key Figures

Earnings period: First quarter 2026 Earnings release date: May 14, 2026 Conference call time ET: 4:30 p.m. ET +2 more

Earnings period

First quarter 2026

Upcoming financial results being reported

Earnings release date

May 14, 2026

Date for first quarter 2026 financial results

Conference call time ET

4:30 p.m. ET

Time of management conference call

Conference call time CT

3:30 p.m. CT

Central Time equivalent for call

Webcast archive duration

30 days

Length of time archived webcast remains available

Previous Earnings date Reports

1 past event · Latest: Mar 03

Same Type 1 event

1. Mar 03

   Earnings date notice

   24h Move

   +0.5%

   Scheduled Q4 and full-year 2025 results with post-close conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).

Participant Call Link:	Click Here
Webcast:	Click Here

 In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.

The live webcast can also be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

About Eton Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has ten commercial rare disease products: KHINDIVI^TM, INCRELEX^®, ALKINDI SPRINKLE^®, DESMODA™, GALZIN^®, HEMANGEOL^®, PKU GOLIKE^®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has four additional product candidates in late-stage development: Amglidia^®, ET-700, ET-800 and ZENEO^® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:

Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Eton Pharmaceuticals (ETON) report Q1 2026 results and what time is the call?

Eton will report Q1 2026 results on Thursday, May 14, 2026, with a call at 4:30 p.m. ET. According to the company, the conference call will begin at 4:30 p.m. ET (3:30 p.m. CT) and include a live audio webcast for investors.

How can investors access the ETON May 14, 2026 webcast for the Q1 2026 results?

Investors can access the live webcast via Eton's Investors website at https://ir.etonpharma.com/. According to the company, the webcast link is on the Investors section and an archived recording will be posted about two hours after the event for 30 days.

Will Eton Pharmaceuticals (ETON) take investor questions during the Q1 2026 earnings call?

Yes, management will take live questions on the conference call and answer emailed investor questions. According to the company, emailed questions can be sent to investorrelations@etonpharma.com in advance or during the event.

How long will the archived ETON Q1 2026 webcast be available after the May 14, 2026 presentation?

The archived webcast will be available for 30 days after posting, which is scheduled about two hours after the event. According to the company, investors can replay the archived audio via the Investors website during that 30-day window.

Where can I send questions ahead of Eton Pharmaceuticals' (ETON) May 14, 2026 earnings call?

Send investor questions to investorrelations@etonpharma.com before or during the call. According to the company, management will answer emailed questions in addition to live participant questions on the conference call.